logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
H

Hans J. Hammers

The University of Texas Southwestern Medical Center
H指数:61
被引数:2.6万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Radiologic, Pathologic, and Deep Learning Predictors of Response to Immune Checkpoint Blockade in Renal Cell Carcinoma Patients Undergoing Post-Treatment Nephrectomy

影像学、病理学和深度学习预测因子：预测接受治疗后肾切除术的肾细胞癌患者对免疫检查点阻断治疗的应答

Modern Pathology
IF5.5
2026-08-240
PRE
Payal Kapur; Alana Christie; Vipul Jarmale; Farzad Tahmasebi; Bingqing Xie; Jeffrey Miyata; Dinesh Rakheja; Jeffrey A. Cadeddu; Vitaly Margulis; Hans Hammers; Tian Zhang; Ivan Pedrosa; James Brugarolas; Satwik Rajaram
Advanced Urologic Cancer Consensus Conference (AUC3) 2025: Expert consensus on the management of renal cell and urinary tract cancers

高级泌尿肿瘤共识会议（AUC3）2025：肾细胞癌和尿路肿瘤管理的专家共识

CA: A Cancer Journal for Clinicians
IF0
2025-12-130
OAAI
Rana R. McKay MD; Sumanta Pal MD; Wanling Xie MS; David Aggen MD, PhD; Laurence Albiges MD, PhD; Andrea Apolo MD; Michael B. Atkins MD; Rick Bangs MBA, PMP; Kathryn E. Beckermann MD, PhD; Joaquim Bellmunt MD, PhD; Stephanie A. Berg DO; Mehmet A. Bilen MD; David Braun MD, PhD; Maria I. Carlo MD; Jason Efstathiou MD, DPhil; Matthew Galsky MD; Petros Grivas MD, PhD; Shilpa Gupta MD; Naomi Haas MD; A. Ari Hakimi MD; Hans Hammers MD, PhD; Daniel Y. C. Heng MSC; Michelle Hirsch MD, PhD; Gopakumar Iyer MD; Eric Jonasch MD; Vadim S. Koshkin MD; Oleksandr Kryvenko MD; Bryan Lewis JD; Roger Li MD; Surena Matin MD; Benjamin Maughan MD, PharmD; David F. McDermott MD; Bradley McGregor MD; Joshua Meeks MD, PhD; Matthew Milowsky MD; Robert Motzer MD; Andrea Necchi MD; Dan Petrylak MD; Sima Porten MD, MPH; Thomas Powles MBBS, MRCP, MD; Brian Rini MD; Brian Shuch MD; Arlene Siefker-Radtke MD; Guru Sonpavde MD; S. Srikala Sridhar MD; Cristina Suarez MD, PhD; Chad Tang MD; Abhishek Tripathi MD; Michiel S. Van Der Heijden MD, PhD; Martin Voss MD; Wenxin Xu MD; Tian Zhang MD; Jonathan Rosenberg MD; Toni K. Choueiri MD
Presence of tertiary lymphoid structures and exhausted tissue-resident T cells determines clinical response to PD-1 blockade in renal cell carcinoma
JOURNAL OF IMMUNOLOGY
IF3.4
2025-11-010
PRE
Wirth, Lena Vanessa; Hugaboom, Miya B.; Street, Kelly; Ruthen, Neil; Jegede, Opeyemi; Schindler, Nicholas; Shah, Valisha; Zaemes, Jacob; El Ahmar, Nourhan; Matar, Sayed; Savla, Varunika; Choueiri, Toni; Denize, Thomas; West, Destiny; Mcdermott, David F.; Plimack, Elizabeth R.; Sosman, Jeffrey; Haas, Naomi; Hurwitz, Michael E.; Hammers, Hans; Stein, Mark; Alter, Robert; Bilen, Mehmet; Signoretti, Sabina; Atkins, Michael B.; Wu, Catherine J.; Braun, David
Novel pembrolizumab-based treatments as first-line therapy in advanced clear cell renal cell carcinoma: Substudy 03A of the open-label, umbrella platform, phase I/II KEYMAKER-U03 trial

新型基于pembrolizumab的治疗方案作为晚期透明细胞肾细胞癌的一线疗法：开放标签、伞形平台、I/II期KEYMAKER-U03试验的子研究03A

Annals of Oncology
IF65.4
2025-10-180
PRE
C. Suarez; C. Rojas; S.J. Shin; P.Yanez Weber; L. Albiges; R. Motzer; H. Hammers; A. Peer; J-L. Lee; W.H. Miller; T. Waddell; V. Neiman; D. Keizman; A.Zwenger Kloster; A. Weickhardt; R. Dziadziuszko; L. Suttner; M. Sharma; J.E. Burgents; T. Powles
Integrated efficacy and safety exposure response (ER) analysis of tivozanib (TIVO) for the treatment of renal cell cancer (RCC)

tivozanib (TIVO) 治疗肾细胞癌 (RCC) 的综合疗效与安全性暴露反应 (ER) 分析

ONCOLOGIST
IF4.2
2025-10-010
OAAI
McGregor, Bradley A.; Choueri, Toni; Albiges, Laurence; Beckermann, Katy; Barthelemy, Philippe; Iacovelli, Roberto; Emambux, Sheik; Molina-Cerrillo, Javier; Garmezy, Benjamin; Barata, Pedro C.; McKay, Rana; Chehrazi-Raffle, Alexander; Hammers, Hans J.; Heng, Daniel Yick Chin; Prins, Klaas; Jin, Bo; Cotreau, Monette; Braendle, Edgar E.; Lebedinsky, Claudia; Motzer, Robert
CD163+Tumor-Associated macrophages and clinical outcomes to First-Line nivolumab therapy in patients with metastatic clear cel renal cell carcinoma: insights from the HCRN GU16-260 trial

CD163+肿瘤相关巨噬细胞与转移性透明细胞肾细胞癌患者接受一线纳武利尤单抗治疗的临床结局：来自HCRN GU16-260试验的见解

ONCOLOGIST
IF4.2
2025-10-010
OAAI
Simsek, Berkay; Paul, Morgan A.; Xie, Wanling; El Ahmar, Nourhan; Matar, Sayed; Laimon, Yasmin Nabil; RobertiDe Oliveira, Gabriel; Mohanna, Razan; Delcea, Andrew; Choueri, Toni; Braun, David; Sun, Maxine; Haas, Naomi B.; Hammers, Hans J.; Bilen, Mehmet; Stein, Mark N.; Sosman, Jeffrey A.; Freeman, Gordon J.; Wu, Catherine; Mcdermott, David; Atkins, Michael B.; Signoretti, Sabina
Presence of tertiary lymphoid structures and exhausted tissue-resident T cells determines clinical response to PD-1 blockade in renal cell carcinoma

三级淋巴结构的存在和耗竭性组织驻留T细胞决定了肾细胞癌对PD-1阻断的临床反应

ONCOLOGIST
IF4.2
2025-10-010
OAAI
Wirth, Lena; Hugaboom, Miya; Street, Kelly; Ruthen, Neil; Jegede, Opeyemi; Schindler, Nicholas; Shah, Valisha; Zaemes, Jacob; El Ahmar, Nourhan; Matar, Sayed; Savla, Varunika; Choueri, Toni; Denize, Thomas; West, Destiny; Mcdermott, David; Plimack, Elizabeth; Sosman, Jeffrey A.; Haas, Naomi B.; Hurwitz, Michael; Hammers, Hans J.; Stein, Mark N.; Alter, Robert; Bilen, Mehmet; Signoretti, Sabina; Atkins, Michael B.; Wu, Catherine; Braun, David
Immunotherapy response correlates in metastatic clear cell renal cell carcinoma from circulating cell-free epigenomes

转移性透明细胞肾细胞癌中循环游离表观基因组与免疫治疗效果的关联

ONCOLOGIST
IF4.2
2025-10-010
OAAI
El Hajj Chehade, Razane; Semaan, Karl; Zhang, Ze; Phillips, Noa; Canniff, John; Savignano, Hunter; Nawfal, Rashad; Eid, Marc; Grisham, Lexi; Prather, Rebecca; Beckermann, Katy; Vaishampayan, Ulka; Haas, Naomi; Hammers, Hans; McDermott, David; Wood, Lauren; Solley, Travis; Rini, Brian; Jonasch, Eric; Choueiri, Toni K.; Freedman, Matthew L.; Haake, Scott M.; Baca, Sylvan C.; Berchuck, Jacob E.
Phase 1b/2 study of batiraxcept alone and in combination with cabozantinib with or without nivolumab for advanced clear cell renal cell carcinoma

I期b/II期研究：评估batiraxcept单药及联合cabozantinib（无论是否联合nivolumab）治疗晚期透明细胞肾细胞癌的疗效。

ONCOLOGIST
IF4.2
2025-06-010
PRE
Beckermann, Kathryn E.; Shah, Neil J.; Campbell, Matthew T.; Haas, Naomi B.; Nelson, Ariel; Ornstein, Moshe C.; Mao, Shifeng; Keshava-Prasad, Holavanahalli S.; Hammers, Hans; Gao, Xin; Gourdin, Theodore; George, Saby; Hoimes, Christopher J.; Hussain, Arif; Jonasch, Eric; Rini, Brian, I; Voss, Martin H.
Tertiary Lymphoid Structures Predict Response to First-Line Nivolumab Therapy in Advanced Renal Cell Carcinoma: Findings from the HCRN GU16-260 Clinical Trial

三级淋巴结构预测晚期肾细胞癌一线Nivolumab治疗的反应: HCRN GU16-260临床试验的结果

LABORATORY INVESTIGATION
IF4.2
2025-03-010
PRE
El Ahmar, Nourhan; Simsek, Berkay; Jegede, Opeyemi; Matar, Sayed; Savla, Varunika; Laimon, Yasmin; Mohanna, Razan; De Oliveira, Gabriel Roberti; Sheshdeh, Aseman Baghari; Delcea, Andrew; Paul, Morgan; Choueiri, Toni; Xie, Wanling; Freeman, Gordon; Braun, David; Haas, Naomi Balzer; Hammers, Hans; Bilen, Mehmet; Stein, Mark; Sosman, Jeffrey; Wu, Catherine; Mcdermott, David; Atkins, Michael; Signoretti, Sabina
A Call for a Neoadjuvant Kidney Cancer Consortium: Lessons Learned from Other Cancer Types

关于建立肾癌新辅助治疗联盟的呼吁：从其他癌症类型中汲取的经验教训

EUROPEAN UROLOGY
IF25.2
2025-01-010
PRE
Bex, Axel; Jewett, Michael; Lewis, Bryan; Abel, E. Jason; Albiges, Laurence; Berg, Stephanie A.; Bratslavsky, Gennady; Braun, David; Brugarolas, James; Choueiri, Toni K.; Finelli, Antonio; George, Daniel; Haas, Naomi B.; Hakimi, A. Ari; Hammers, Hans; Hirsch, Michelle; Jonasch, Eric; Kapur, Payal; Linehan, W. Marston; Master, Viraj; Mcgregor, Bradley; Mckay, Rana R.; Mehra, Rohit; Pal, Sumantha; Poteat, Susan; Powles, Thomas B.; Rossi, Sabrina H.; Shapiro, Daniel D.; Signoretti, Sabina; Singer, Eric A.; Stravin, Chuck; Tannir, Nizar; Vaishampayan, Ulka; Xu, Wenxin
Nivolumab plus ipilimumab versus sunitinib for fi rst-line treatment of advanced renal cell carcinoma: extended 8-year follow-up results of efficacy and safety from the phase III CheckMate 214 trial

Nivolumab联合ipilimumab与舒尼替尼用于晚期肾细胞癌的一线治疗: CheckMate 214 III期试验的疗效和安全性的8年随访结果

ANNALS OF ONCOLOGY
IF65.4
2024-11-010
OAAI
Tannir, N. M.; Albiges, L.; Mcdermott, D. F.; Burotto, M.; Choueiri, T. K.; Hammers, H. J.; Barthelemy, P.; Plimack, E. R.; Portat, C.; George, S.; Donskov, F.; Atkins, M. B.; Gurney, H.; Kollmannsberger, C. K.; Grimm, M. -o.; Barrios, C.; Tomita, Y.; Castellano, D.; Gruenwald, V.; Rini, B. I.; Jiang, R.; Desilva, H.; Fedorov, V.; Lee, C. -w.; Motzer, R. J.
Tivozanib plus nivolumab versus tivozanib monotherapy in patients with renal cell carcinoma following an immune checkpoint inhibitor: results of the phase 3TiNivo-2 Study

免疫检查点抑制剂后肾细胞癌患者Tivozanib联合nivolumab与tivozanib单药治疗的比较: 3TiNivo-2期研究的结果

LANCET
IF88.5
2024-10-014
PRE
Choueiri, Toni K.; Albiges, Laurence; Barthelemy, Philippe; Iacovelli, Roberto; Emambux, Sheik; Molina-Cerrillo, Javier; Garmezy, Benjamin; Barata, Pedro; Basu, Arnab; Bourlon, Maria; Moon, Helen; Ratta, Raffaele; McKay, Rana R.; Chehrazi-Raffle, Alexander; Hammers, Hans; Heng, Daniel Y. C.; Braendle, Edgar; Beckermann, Kathryn E.; McGregor, Bradley A.; Motzer, Robert J.
Validation of the Lung Immune Prognostic Index (LIPI) as a prognostic biomarker in metastatic renal cell carcinoma

肺免疫预后指数 (LIPI) 作为转移性肾细胞癌预后生物标志物的验证

EUROPEAN JOURNAL OF CANCER
IF7.1
2024-06-013
PRE
Carril-Ajuria, Lucia; Lavaud, Pernelle; Dalban, Cecile; Negrier, Sylvie; Gravis, Gwenaelle; Motzer, Robert J.; Chevreau, Christine; Tannir, Nizar M.; Oudard, Stephane; McDermott, David F.; Laguerre, Brigitte; Hammers, Hans J.; Barthelemy, Philippe; Plimack, Elizabeth R.; Borchiellini, Delphine; Gross-Goupil, Marine; Jiang, Ruiyun; Lee, Chung-Wei; de Silva, Heshani; Rini, Brian I.; Escudier, Bernard; Albiges, Laurence
Molecular analysis of primary and metastatic sites in patients with renal cell carcinoma
JOURNAL OF CLINICAL INVESTIGATION
IF13.6
2024-05-300
OAAI
Gulati, Shuchi; Barata, Pedro C.; Elliott, Andrew; Bilen, Mehmet Asim; Burgess, Earle F.; Choueiri, Toni K.; Darabi, Sourat; Dawson, Nancy Ann; Gartrell, Benjamin Adam; Hammers, Hans J.; Heath, Elisabeth I.; Magee, Daniel; Rao, Arpit; Ryan, Charles J.; Twardowski, Przemyslaw; Wei, Shuanzeng; Brugarolas, James; Zhang, Tian; Zibelman, Matthew R.; Nabhan, Chadi; McKay, Rana R.

研究方向

暂未获取到该数据
D
David F. McDermott
H 指数:109论文数:1,058被引数:8.8万
E
Elizabeth R. Plimack
H 指数:79论文数:766被引数:4.8万
R
Robert J. Motzer
H 指数:148论文数:1,602被引数:12.3万
B
Brian I. Rini
H 指数:122论文数:1,338被引数:7.7万
T
Toni K. Choueiri
H 指数:149论文数:2,478被引数:12.6万
N
Naomi B. Haas
H 指数:54论文数:539被引数:1.3万
S
Saby George
H 指数:45论文数:329被引数:2.1万
J
Jeffrey A. Sosman
H 指数:122论文数:904被引数:12.7万
H
Howard Gurney
H 指数:64论文数:457被引数:3.6万
F
Frede Donskov
H 指数:62论文数:369被引数:2.9万